Physician Search
 |
 |
 |
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)
Multiple Cancer Types
Colon,
Rectal
II/III
Ciombor, Kristen
NCT05174169
SWOGGI008
A Phase 3 randomized, placebo-controlled trial evaluating Memantine (IND# 149832) for neurocognitive protection in children undergoing cranial radiotherapy as part of treatment for primary central nervous system tumors.
Multiple Cancer Types
Neuro-Oncology,
Pediatrics
III
Esbenshade, Adam
NCT04939597
COGACCL2031
An Open-Label, Phase 1b/2 Study to Evaluate the Safety and Efficacy of Fruquintinib in Combination with Tislelizumab in Patients with Advanced Solid Tumors
Multiple Cancer Types
Miscellaneous,
Phase I
I/II
Eng, Cathy
NCT04577963
VICCGIP2223
Pediatric Acute Leukemia (PedAL) Screening Trial Developing New Therapies for Relapsed Leukemias.
Multiple Cancer Types
Pediatric Leukemia,
Pediatric Lymphoma,
Pediatrics
N/A
Zarnegar-Lumley, Sara
NCT04726241
COGAPAL2020SC
A Phase 1b, Open-Label, Dose-Escalation and Dose-Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of Mipasetamab Uzoptirine (ADCT-601) Monotherapy and in Combination with Other Anti-Cancer Therapies in Patients with Selected Advanced Solid Tumors
Miscellaneous
Miscellaneous
Miscellaneous
I
Davis, Elizabeth
NCT05389462
VICCPHI2225
A Multicenter, Open-Label, Phase 1a/b Study of HC-7366 in Subjects with Advanced Solid Tumors.
Multiple Cancer Types
Miscellaneous,
Phase I
I
Berlin, Jordan
NCT05121948
VICCPHI2229
NRG-GY023: A Randomized Phase II Trial of Triplet Therapy (a PD-L1 Inhibitor Durvalumab (MEDI4736) in Combination with Olaparib and Cediranib) Compared to Olaparib and Cediranib or Durvalumab (MEDI4736) and Cediranib or Standard of Care Chemotherapy in Women with Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Primary Peritoneal or Fallopian Cancer Who Have Received Prior Bevacizumab
Multiple Cancer Types
Gynecologic,
Ovarian
II
Brown, Alaina
NCT04739800
NRGGYNGY023
Expanded Access to Trametinib for a child with Plexiform Neurofibroma in NF1
Pediatrics
Pediatrics
Pediatrics
N/A
Esbenshade, Adam
VICCPED2251
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of CAEL-101 and Plasma Cell Dyscrasia Treatment versus Placebo and Plasma Cell Dyscrasia Treatment in Plasma Cell Dyscrasia Treatment-Nave Patients with Mayo Stage IIIa AL Amyloidosis
Hematologic
Hematologic
Hematologic
III
Sengsayadeth, Salyka
NCT04512235
VICCPCL2080
Multiparametric MRI as a Non-Invasive Biomarker of the Tumor Microenviroment in Breast Cancer
Breast
Breast
Breast
N/A
Kennedy, Laura
NCT04803084
VICCBRE20104
